LINC02618

Across TCGA pan-cancer cohorts, LINC02618 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02618’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02618 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02618 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and BLCA are the cancer types where LINC02618 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02618 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.142	<.001	12	view →
THCA	All	All	−0.179	<.001	8	view →
BLCA	All	IV	−0.264	<.001	7	view →
LUSC	All	II,III,IV	−0.346	<.001	6	view →
KIRP	All	All	−0.112	.002	6	view →
LIHC	All	All	+0.077	<.001	4	view →
READ	All	All	−0.306	.004	2	view →
UCEC	All	All	−0.249	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02618–KIRC

Open the KIRC breakdown →